Lowered oxygen tension induces expression of the hypoxia marker MN/carbonic anhydrase IX in the absence of hypoxia-inducible factor 1α stabilization: A role for phosphatidylinositol 3′-kinase

Cancer Research

Volumn 62, Issue 15, 2002, Pages 4469-4477

  Kaluz, Stefan ^a,d   Kaluzová, Milota ^a,d   Chrastina, Adrian ^a   Olive, Peggy L ^b   Pastoreková, Silvia ^a   Pastorek, Jaromír ^a   Lerman, Michael I ^c   Stanbridge, Eric J ^d  

^a INSTITUTE OF VIROLOGY   (Slovakia)

^b BRITISH COLUMBIA CANCER RESEARCH CENTRE   (Canada)

^c NATIONAL CANCER INSTITUTE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; CARBONATE DEHYDRATASE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; PHOSPHATIDYLINOSITOL 3 KINASE; WORTMANNIN;

ARTICLE; CELL DENSITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE MARKER; ENZYME ACTIVATION; HELA CELL; HUMAN; HUMAN CELL; HYPOXIA; OXYGEN TENSION; PH; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; PROTEIN STABILITY; SIGNAL TRANSDUCTION; SOLID TUMOR; TRANSCRIPTION REGULATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANTIGENS, NEOPLASM; CARBONIC ANHYDRASES; CELL COUNT; ENZYME ACTIVATION; FIBROSARCOMA; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUCOSE; HELA CELLS; HUMANS; HYDROGEN-ION CONCENTRATION; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; NEOPLASM PROTEINS; OXYGEN; PROMOTER REGIONS (GENETICS); TRANSCRIPTION FACTORS;

EID: 0036682009     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Cloning and characterization of CA9, a human tumor-associated protein with a domain homologous to carbonic anhydrase and a putative helix-loop-helix DNA binding segment
2. Expression of MaTu-MN protein in human tumor cultures and in clinical specimens
3. Expression of hypoxia-inducible cell-surface transmembrane carbonic anhydrases in human cancer
4. Down-regulation of transmembrane carbonic anhydrases in renal cell carcinoma cell lines by wild-type von Hippel-Lindau transgenes
5. Carbonic anhydrase inhibitor suppresses invasion of renal cancer cells in vitro
6. Hypoxia-inducible expression of tumor-associated carbonic anhydrases
7. Carbonic anhydrase (CAIX) expression, a potential new intrinsic marker of hypoxia: Correlations with tumor oxygen measurements and prognosis in locally advanced carcinoma of the cervix
8. General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia
9. Epidermal growth factor receptor transcriptionally up-regulates vascular endothelial growth factor expression in human glioblastoma cells via a pathway involving phospatidylinositol 3′-kinase and distinct from that induced by hypoxia
10. Constitutive SP1 activity is essential for differential constitutive expression of vascular endothelial growth factor in human pancreatic adenocarcinoma
11. Carbonic anhydrase 9 as an endogenous marker for hypoxic cells in cervical cancer
12. Transcriptional regulation of the MN/CA 9 gene coding for the tumor-associated carbonic anhydrase IX. Identification and characterization of a proximal silencer element
13. Characterization of the MN/CA 9 promoter proximal region: A role for SP and API factors
14. 2 tension
15. Hypoxia inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth
16. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
17. Regulation of the hypoxia-inducible factor 1α by the inflammatory mediators nitric oxide and tumor necrosis factor-α in contrast to desferroxamine and phenylarsine oxide
18. A non-hypoxic. ROS-sensitive pathway mediates TNF-α-dependent regulation of HIF-1α
19. Thrombin activates the hypoxia-inducible factor-1 signaling pathway in vascular smooth muscle cells: Role of the p22(phox)-containing NADPH oxidase
20. Nonhypoxic pathway mediates the induction of hypoxia-inducible factor 1α in vascular smooth muscle cells
21. Insulin induces transcription of target genes through the hypoxia-inducible factor HIF-1α ARNT
22. Phosphatidylinositol 3-kinase signaling controls levels of hypoxia-inducible factor 1
23. Reporter constructs with low background activity utilizing the cat gene
24. Phosphatidylinositol 3-kinase links the interleukin-2 receptor to protein kinase B and p70 S6 kinase
25. Selection and analysis of a mutant cell line defective in the hypoxia-inducible factor-1α-subunit (HIF-1α
26. A novel quasi-viral agent, MaTu, is a two-component system
27. Regulation of vascular endothelial growth factor expression in human colon carcinoma cells by cell density
28. Cell density mediated pericellular hypoxia leads to induction of HIF-1α via nitric oxide and Ras/MAP kinase mediated signaling pathways
29. Relation of vascular endothelial growth factor production to expression and regulation of hypoxia-inducible factor-1α and hypoxia-inducible factor 2α in human bladder tumors and cell lines
30. Induction of vascular endothelial growth factor by hypoxia is modulated by a phosphatidylinositol 3-kinase/Akt signalling pathway in Ha-ras-transformed cells through a hypoxia inducible factor-1 transcriptional element
31. Modulation of hypoxia-inducible factor 1α expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/Akt/FRAP pathway in human prostate cancer cells: Implications for tumor angiogenesis and therapeutics
32. Phosphatidylinositol 3-kinase signalling mediates angiogenesis and expression of vascular endothelial growth factor in endothelial cells
33. HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1α (HIF-1α) synthesis: Novel mechanism for HIF-1-mediated vascular endothelial growth factor expression
34. Up-regulation of vascular endothelial growth factor in response to glucose deprivation
35. Hypoxia and acidosis independently up-regulate vascular endothelial growth factor transcription in brain tumors in vivo
36. Oxygen diffusion and oxygen depletion problems in radiobiology
37. High cell density induces vascular endothelial growth factor expression via protein tyrosine phosphorylation
38. Oncogenic kinase signalling
39. Regulation of cell death protease caspase-9 by phosphorylation
40. Regulation of Akt/PKB activity, cellular growth, and apoptosis in prostate carcinoma cells by MMAC/PTEN
41. Activation of phosphatidylinositol 3-kinase is sufficient for cell cycle entry and promotes cellular changes characteristic of oncogenic transformation
42. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer
43. Lack of evidence for the involvement of the phosphoinositide 3-kinase/Akt pathway in the activation by hypoxia inducible factors by low oxygen tension
44. PI3-K/Akt signaling is neither required for hypoxic stabilization of HIF-1α nor sufficient for HIF-1-dependent target gene transcription
45. Hypoxia activates Akt and induces phosphorylation of GSK-3 in PCI2 cells
46. SP1 and Krüppel-like factor family of transcription factors in cell growth regulation and cancer
47. p42/p44 MAP kinase module plays a key role in the transcriptional regulation of the vascular endothelial growth factor gene in fibroblasts
48. Sp1 phosphorylation regulates apoptosis via extracellular FasL-Fas engagement